GLB1 Gene GM1-gangliosidosis type 2 Genetic Test
Test Name: GLB1 Gene GM1-gangliosidosis type 2 Genetic Test
Components: Blood or Extracted DNA or One drop Blood on FTA Card
Price: 4400.0 AED
Report Delivery: 3 to 4 Weeks
Method: NGS Technology
Test type: Metabolic Disorders
Doctor: General Physician
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for GLB1 Gene GM1-gangliosidosis type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with GM1-gangliosidosis type 2.
Test Details
The GLB1 gene is responsible for producing an enzyme called beta-galactosidase, which is involved in breaking down a substance called GM1-ganglioside in the body. GM1-gangliosidosis type 2 is a rare genetic disorder characterized by the deficiency of beta-galactosidase enzyme activity.
NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of GM1-gangliosidosis type 2, NGS testing can be used to identify mutations or variations in the GLB1 gene that may be responsible for the disorder.
NGS genetic testing can provide valuable information about an individual’s genetic makeup, including identifying specific genetic variants that may be associated with GM1-gangliosidosis type 2. This information can be helpful in confirming a diagnosis, assessing disease severity, and guiding treatment options.
It is important to note that NGS genetic testing for GM1-gangliosidosis type 2 should be performed by a qualified geneticist or genetic counselor who can interpret the results and provide appropriate genetic counseling. Genetic testing results should always be interpreted in conjunction with a thorough clinical evaluation to ensure accurate diagnosis and appropriate management.
| Test Name | GLB1 Gene GM1-gangliosidosis type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for GLB1 Gene GM1-gangliosidosis type 2 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with GM1-gangliosidosis type 2 |
| Test Details |
The GLB1 gene is responsible for producing an enzyme called beta-galactosidase, which is involved in breaking down a substance called GM1-ganglioside in the body. GM1-gangliosidosis type 2 is a rare genetic disorder characterized by the deficiency of beta-galactosidase enzyme activity. NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technology to analyze multiple genes simultaneously. In the case of GM1-gangliosidosis type 2, NGS testing can be used to identify mutations or variations in the GLB1 gene that may be responsible for the disorder. NGS genetic testing can provide valuable information about an individual’s genetic makeup, including identifying specific genetic variants that may be associated with GM1-gangliosidosis type 2. This information can be helpful in confirming a diagnosis, assessing disease severity, and guiding treatment options. It is important to note that NGS genetic testing for GM1-gangliosidosis type 2 should be performed by a qualified geneticist or genetic counselor who can interpret the results and provide appropriate genetic counseling. Genetic testing results should always be interpreted in conjunction with a thorough clinical evaluation to ensure accurate diagnosis and appropriate management. |
